GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chengda Pharmaceuticals Co Ltd (SZSE:301201) » Definitions » PB Ratio

Chengda Pharmaceuticals Co (SZSE:301201) PB Ratio : 1.39 (As of May. 05, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Chengda Pharmaceuticals Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-05), Chengda Pharmaceuticals Co's share price is ¥20.21. Chengda Pharmaceuticals Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥14.50. Hence, Chengda Pharmaceuticals Co's PB Ratio of today is 1.39.

The historical rank and industry rank for Chengda Pharmaceuticals Co's PB Ratio or its related term are showing as below:

SZSE:301201' s PB Ratio Range Over the Past 10 Years
Min: 1.17   Med: 2.05   Max: 18.8
Current: 1.39

During the past 10 years, Chengda Pharmaceuticals Co's highest PB Ratio was 18.80. The lowest was 1.17. And the median was 2.05.

SZSE:301201's PB Ratio is ranked better than
66.46% of 960 companies
in the Drug Manufacturers industry
Industry Median: 1.97 vs SZSE:301201: 1.39

During the past 12 months, Chengda Pharmaceuticals Co's average Book Value Per Share Growth Rate was 0.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 55.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 46.90% per year.

During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Chengda Pharmaceuticals Co was 67.10% per year. The lowest was -39.10% per year. And the median was 28.90% per year.

Back to Basics: PB Ratio


Chengda Pharmaceuticals Co PB Ratio Historical Data

The historical data trend for Chengda Pharmaceuticals Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengda Pharmaceuticals Co PB Ratio Chart

Chengda Pharmaceuticals Co Annual Data
Trend Dec08 Dec09 Dec10 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 2.22 1.73

Chengda Pharmaceuticals Co Quarterly Data
Dec17 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.93 1.80 1.76 1.73 1.40

Competitive Comparison of Chengda Pharmaceuticals Co's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Chengda Pharmaceuticals Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chengda Pharmaceuticals Co's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chengda Pharmaceuticals Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Chengda Pharmaceuticals Co's PB Ratio falls into.



Chengda Pharmaceuticals Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Chengda Pharmaceuticals Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=20.21/14.504
=1.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Chengda Pharmaceuticals Co  (SZSE:301201) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Chengda Pharmaceuticals Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Chengda Pharmaceuticals Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Chengda Pharmaceuticals Co (SZSE:301201) Business Description

Traded in Other Exchanges
N/A
Address
36 Huanghe Road, Huimin Street, Jiashan County, Zhejiang Province, Jiaxing, CHN, 314100
Chengda Pharmaceuticals Co Ltd is engaged in the research and development, production and sales of L-carnitine series products. The company mainly produces raw materials, food additives, feed additives, antibiotics, anti-cancer, anti-virus and other series of pharmaceutical intermediates. The products are sold to more than 30 countries and regions.

Chengda Pharmaceuticals Co (SZSE:301201) Headlines

No Headlines